Bill to pay for multi-cancer early detection screening test has bipartisan support, but just ran out of time last session.

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Height has been linked to an increased risk of certain cancers, including pancreatic, uterine, and breast cancer, due to ...

The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Prostate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment remaining a challenge despite decades of research. For years, the prostate-specific ...

Personalized medicine aims to tailor treatments to individual patients. Until now, this has been done using a small number of parameters to predict the course of a disease. However, these few ...

Figuring out what causes cancer can be a frightening mystery, but sometimes it's in your genes. So who should get genetic testing for cancer? And when?

"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...

Triple negative breast cancer wreaks a particularly heavy toll in certain regions and populations, with stark differences in both incidence and survival rates ...

Seattle doctors developed a blood test that determines the parental origin of the RB1 mutation in retinoblastoma.

Distinct epigenetic patterns established during early development influence an individual’s risk of developing cancer later ...